Onex Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.15 Cr
as on 04-12-2024
- Paid Up Capital ₹ 1.15 Cr
as on 04-12-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.23 Cr
as on 04-12-2024
- Revenue 47.13%
(FY 2022)
- Profit 88.94%
(FY 2022)
- Ebitda -6.77%
(FY 2022)
- Net Worth 8.15%
(FY 2022)
- Total Assets -1.20%
(FY 2022)
About Onex Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.15 Cr and a paid-up capital of Rs 1.15 Cr.
The company currently has active open charges totaling ₹8.23 Cr.
Krishnamurthy, Palani Sakthivel, Muthukrishnan Mahendrakumar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33110TN2009PTC071663
- Company No.
071663
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Onex Life Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muthukrishnan Mahendrakumar  | Managing Director | 19-May-2009 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Palani Sakthivel | Director | 19-May-2009 | Current |
| Krishnamurthy | Director | 13-Dec-2013 | Current |
| Muralikrishnan Sominedi | Director | 13-Dec-2013 | Current |
| Ramanujam Senthooraiya | Director | 13-Dec-2013 | Current |
Financial Performance of Onex Life Science.
Onex Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.13% increase. The company also saw a substantial improvement in profitability, with a 88.94% increase in profit. The company's net worth moved up by a moderate rise of 8.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Onex Life Science?
Unlock access to Onex Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Xeno Pharmaaceuticals Private LimitedActive 15 years 8 months
Palani Sakthivel and Muthukrishnan Mahendrakumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 05 Mar 2024 | ₹1.85 Cr | Open |
Canara Bank Creation Date: 01 Mar 2022 | ₹2.30 Cr | Open |
Others Creation Date: 26 Sep 2017 | ₹2.00 Cr | Open |
How Many Employees Work at Onex Life Science?
Onex Life Science has a workforce of 8 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Onex Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onex Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
